Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06HFV
|
||||
Former ID |
DNC005627
|
||||
Drug Name |
5-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyrimidine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527456] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H11FN2
|
||||
Canonical SMILES |
C1CC(=CC2=CN=CN=C2)C3=C1C=C(C=C3)F
|
||||
InChI |
1S/C14H11FN2/c15-13-3-4-14-11(1-2-12(14)6-13)5-10-7-16-9-17-8-10/h3-9H,1-2H2/b11-5+
|
||||
InChIKey |
LEJPKWXGQFBXRX-VZUCSPMQSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 19 | Target Info | Inhibitor | [527456] | |
17 alpha-hydroxylase-C17, 20-lyase | Target Info | Inhibitor | [527456] | ||
Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [527456] | ||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
WikiPathways | Metapathway biotransformation | ||||
Tryptophan metabolism | |||||
Oxidation by Cytochrome P450 | |||||
Ovarian Infertility Genes | |||||
Metabolism of steroid hormones and vitamin D | |||||
FSH signaling pathway | |||||
Integrated Breast Cancer Pathway | |||||
Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation | |||||
Steroid Biosynthesis | |||||
Glucocorticoid & Mineralcorticoid Metabolism | |||||
Prostate Cancer | |||||
Corticotropin-releasing hormone | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.